Securities Exchange Act

Schall Law Firm seeks investors in $FSK securities fraud class action, alleging false statements on portfolio restructuring, valuation, and dividends.

Vital Farms faces class action lawsuit alleging securities violations over understated ERP system implementation risks. Deadline May 26, 2026.

Schall Law Firm launches class action lawsuit against ImmunityBio for alleged securities fraud over false Anktiva drug statements between January-March 2026.

Hercules Capital faces securities fraud lawsuit alleging misrepresentations in loan due diligence and portfolio valuations. Investors sought for class action.

DJS Law Group files class action against $CWH for alleged false statements about inventory management capabilities during April 2025-February 2026 period.

Nektar Therapeutics faces class action lawsuit alleging securities fraud over alleged REZOLVE-AA trial misstatements involving improper patient enrollment procedures.

REGENXBIO faces class action securities fraud lawsuit over allegedly concealed safety data for gene therapy RGX-111, triggered by CNS tumor discovery in clinical trial.

DJS Law Group sues $FBRT for allegedly making false statements about dividend sustainability. Class period spans November 2024 to February 2026.

Schall Law Firm seeks $RGNX investors for securities fraud class action alleging false statements about RGX-111 candidate, following tumor discovery in trial participant.

DJS Law Group files class action against $CWH for allegedly making false statements about inventory management capabilities, harming profitability.

$LU faces securities lawsuit alleging false financial statements and weak internal controls from April 2023 through January 2025. Class action deadline set for May 2026.

Federal court certifies class action against Biogen for alleged 2021 securities misrepresentations, affecting purchasers during June-July period.

Alight Inc. ($ALIT) faces class action lawsuit alleging false statements, failed business execution, and unsustainable dividend commitments under Securities Exchange Act.

Eos Energy Enterprises ($EOSE) faces class action lawsuit alleging false statements about production capabilities and battery performance, with downtime exceeding forecasts.

Schall Law Firm seeks investors in class action against $NKTR over alleged false statements regarding REZOLVE-AA trial enrollment and integrity.

DJS Law Group files class action against $FBRT for allegedly overstating dividend prospects and misleading shareholders about $0.355 quarterly distributions.

Schall Law Firm seeks investors in $RGNX securities fraud class action over allegedly misleading statements about RGX-111 clinical trial data.

Schall Law Firm seeks $BYND investors for class action alleging false statements about long-lived assets and impairment charges between February-November 2025.

Franklin BSP Realty Trust faces class action lawsuit alleging securities violations over false dividend sustainability statements, requiring shareholders to evaluate exposure.

Schall Law Firm pursuing class action against Franklin BSP Realty Trust for allegedly overstating dividend sustainability. Investors who bought shares between November 2024 and February 2026 may join suit.